Ru Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Khardah Municipal Corp., West Bengal, India, established in 2018.
2018 Khardah Municipal Corp., West Bengal, India Active
Last Updated:
Access Report
About Ru Pharmaceutical Private Limited

Ru Pharmaceutical Private Limited, a active private limited company, was established on 01 October 2018 in Khardah Municipal Corp., West Bengal, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33112WB2018PTC228279. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Chandan Nabakumar Saha (Director), Suvadip Jana (Director), Sandip Nag (Director). It is based at C/O-Kajal Kumar Saha S/O Naba Kumar Saha Hindpark,Bandipur, Rahara, Ward No.5, Khardah Municipal Corp., West Bengal, 700118.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33112WB2018PTC228279

  • Registration Number

    228279

  • Incorporation Date

    01 October 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 5 Months
Company report

Ru Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ru Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ru Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandan Nabakumar Saha Director 01 Oct 2018 Current
Suvadip Jana Director 01 Oct 2018 Current
Sandip Nag Director 01 Oct 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ru Pharmaceutical.

Enhance accessibility to Ru Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ru Pharmaceutical revenue growth over time
Ru Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ru Pharmaceutical?

Unlock access to Ru Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ru Pharmaceutical?

Unlock and access historical data on people associated with Ru Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ru Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ru Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ru Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Progress on Chandan Nabakumar Saha was appointed as a Director was appointed as a Director on 01 Oct 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Director Appointment

    Progress on Suvadip Jana was appointed as a Director was appointed as a Director on 01 Oct 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Director Appointment

    Sandip Nag was appointed as a Director was appointed as a Director on 01 Oct 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.

  • Company Incorporation

    Ru Pharmaceutical Private Limited was registered on 01 Oct 2018 with Roc Kolkata & aged 7 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ru Pharmaceutical Private Limited?

The CIN of Ru Pharmaceutical Private Limited is U33112WB2018PTC228279.

Where is Ru Pharmaceutical Private Limited headquartered?

Ru Pharmaceutical Private Limited is headquartered at C/O-Kajal Kumar Saha S/O Naba Kumar Saha Hindpark,Bandipur, Rahara, Ward No.5, Khardah Municipal Corp., West Bengal, 700118.

When was Ru Pharmaceutical Private Limited incorporated?

Ru Pharmaceutical Private Limited was incorporated on 01 October 2018.

Who are the current directors of Ru Pharmaceutical Private Limited?

The current directors of Ru Pharmaceutical Private Limited are

What is the primary industry of Ru Pharmaceutical Private Limited?

The primary industry of Ru Pharmaceutical Private Limited is Pharma.

Is Ru Pharmaceutical Private Limited a listed company?

Ru Pharmaceutical Private Limited is unlisted.

What is the capital structure of Ru Pharmaceutical Private Limited?

The authorized capital of Ru Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available